Teva Pharmaceuticals USA recalls Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabi…

Recall date

September 6, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0131-2020

FDA classification

Class III

Brand / firm

Teva Pharmaceuticals USA

Sold / distributed

Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.

Why it was recalled

GMP Deviation: lot not intended for commercial distribution.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30